消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2022 ASCRS临床实践指南：结肠癌的治疗

2022-01-10 美国结肠和直肠外科医师学会 Dis Colon Rectum

结肠癌消化道肿瘤

2022年美国结肠和直肠外科医师学会(ASCRS)结肠癌治疗指南发布，该指南基于2017年发布的指南的参数，共提出11条新建议、更新10条建议和2条排除建议。

中文标题：

2022 ASCRS临床实践指南：结肠癌的治疗

英文标题：

The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Colon Cancer

发布机构：

美国结肠和直肠外科医师学会

发布日期：

2022-01-10

简要介绍：

2022年美国结肠和直肠外科医师学会(ASCRS)结肠癌治疗指南发布，该指南基于2017年发布的指南的参数，共提出11条新建议、更新10条建议和2条排除建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2022 ASCRS临床实践指南：结肠癌的治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=1b44b1c002315a0d, title=2022 ASCRS临床实践指南：结肠癌的治疗, enTitle=The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Colon Cancer, guiderFrom=Dis Colon Rectum, authorId=0, author=, summary=2022年美国结肠和直肠外科医师学会(ASCRS)结肠癌治疗指南发布，该指南基于2017年发布的指南的参数，共提出11条新建议、更新10条建议和2条排除建议。, cover=https://img.medsci.cn/2022110/1641819220560_1608702.jpg, journalId=0, articlesId=null, associationId=463, associationName=美国结肠和直肠外科医师学会, associationIntro=美国结肠直肠癌的外科医生(ASCRS)学会是第一个对结肠直肠癌外科医生和其他外科的学会，她致力于推进科学与实践,缓解患者的治疗疾病和紊乱影响结肠、直肠和肛门疾病以及功能紊乱对患者的影响。已经有超过1000家学会的2600多个成员都认可了美国董事会结肠直肠癌的外科手术。, copyright=0, guiderPublishedTime=Mon Jan 10 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2022年美国结肠和直肠外科医师学会(ASCRS)结肠癌治疗指南发布，该指南基于2017年发布的指南的参数，共提出11条新建议、更新10条建议和2条排除建议。</span></p>, tagList=[TagDto(tagId=249, tagName=结肠癌), TagDto(tagId=439, tagName=消化道肿瘤)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=76, categoryName=胃肠外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=249, guiderKeyword=结肠癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6644, appHits=215, showAppHits=0, pcHits=1059, showPcHits=6428, likes=1, shares=40, comments=11, approvalStatus=1, publishedTime=Mon Jan 10 20:50:34 CST 2022, publishedTimeString=2022-01-10, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Mon Jan 10 20:57:09 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 19:21:32 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 ASCRS临床实践指南：结肠癌的治疗.pdf)])
2022 ASCRS临床实践指南：结肠癌的治疗.pdf
下载请点击：
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1190156, encodeId=2c951190156c1, content=翻译不了😂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd875646858, createdName=ms4000000553876660, createdTime=Fri Feb 04 16:52:37 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188272, encodeId=29c711882e2fa, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d7c6483823, createdName=ms3000001881622928, createdTime=Wed Jan 26 13:06:48 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186193, encodeId=2fb31186193b9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220119/25c56abd1c73456fafc2a77da3faa9ad/178147ca64fe4cb5a9f75a9ea1f7c709.jpg, createdBy=34835566428, createdName=Dr.xiaohe, createdTime=Wed Jan 19 22:48:32 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184078, encodeId=1f7111840e878, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e0c5158090, createdName=146ae447m92(暂无昵称), createdTime=Thu Jan 13 23:20:45 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183419, encodeId=fc4111834199b, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 12 07:25:34 CST 2022, time=2022-01-12, status=1, ipAttribution=)]
    2022-02-04 ms4000000553876660

    翻译不了😂

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1190156, encodeId=2c951190156c1, content=翻译不了😂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd875646858, createdName=ms4000000553876660, createdTime=Fri Feb 04 16:52:37 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188272, encodeId=29c711882e2fa, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d7c6483823, createdName=ms3000001881622928, createdTime=Wed Jan 26 13:06:48 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186193, encodeId=2fb31186193b9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220119/25c56abd1c73456fafc2a77da3faa9ad/178147ca64fe4cb5a9f75a9ea1f7c709.jpg, createdBy=34835566428, createdName=Dr.xiaohe, createdTime=Wed Jan 19 22:48:32 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184078, encodeId=1f7111840e878, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e0c5158090, createdName=146ae447m92(暂无昵称), createdTime=Thu Jan 13 23:20:45 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183419, encodeId=fc4111834199b, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 12 07:25:34 CST 2022, time=2022-01-12, status=1, ipAttribution=)]
    2022-01-26 ms3000001881622928

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1190156, encodeId=2c951190156c1, content=翻译不了😂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd875646858, createdName=ms4000000553876660, createdTime=Fri Feb 04 16:52:37 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188272, encodeId=29c711882e2fa, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d7c6483823, createdName=ms3000001881622928, createdTime=Wed Jan 26 13:06:48 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186193, encodeId=2fb31186193b9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220119/25c56abd1c73456fafc2a77da3faa9ad/178147ca64fe4cb5a9f75a9ea1f7c709.jpg, createdBy=34835566428, createdName=Dr.xiaohe, createdTime=Wed Jan 19 22:48:32 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184078, encodeId=1f7111840e878, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e0c5158090, createdName=146ae447m92(暂无昵称), createdTime=Thu Jan 13 23:20:45 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183419, encodeId=fc4111834199b, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 12 07:25:34 CST 2022, time=2022-01-12, status=1, ipAttribution=)]
    2022-01-19 Dr.xiaohe

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1190156, encodeId=2c951190156c1, content=翻译不了😂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd875646858, createdName=ms4000000553876660, createdTime=Fri Feb 04 16:52:37 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188272, encodeId=29c711882e2fa, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d7c6483823, createdName=ms3000001881622928, createdTime=Wed Jan 26 13:06:48 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186193, encodeId=2fb31186193b9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220119/25c56abd1c73456fafc2a77da3faa9ad/178147ca64fe4cb5a9f75a9ea1f7c709.jpg, createdBy=34835566428, createdName=Dr.xiaohe, createdTime=Wed Jan 19 22:48:32 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184078, encodeId=1f7111840e878, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e0c5158090, createdName=146ae447m92(暂无昵称), createdTime=Thu Jan 13 23:20:45 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183419, encodeId=fc4111834199b, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 12 07:25:34 CST 2022, time=2022-01-12, status=1, ipAttribution=)]
    2022-01-13 146ae447m92(暂无昵称)

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1190156, encodeId=2c951190156c1, content=翻译不了😂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd875646858, createdName=ms4000000553876660, createdTime=Fri Feb 04 16:52:37 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188272, encodeId=29c711882e2fa, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d7c6483823, createdName=ms3000001881622928, createdTime=Wed Jan 26 13:06:48 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186193, encodeId=2fb31186193b9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220119/25c56abd1c73456fafc2a77da3faa9ad/178147ca64fe4cb5a9f75a9ea1f7c709.jpg, createdBy=34835566428, createdName=Dr.xiaohe, createdTime=Wed Jan 19 22:48:32 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184078, encodeId=1f7111840e878, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e0c5158090, createdName=146ae447m92(暂无昵称), createdTime=Thu Jan 13 23:20:45 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183419, encodeId=fc4111834199b, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 12 07:25:34 CST 2022, time=2022-01-12, status=1, ipAttribution=)]
    2022-01-12 微探

    学习学习

    0

相关指南

2020 AIOM指南：早期结肠癌患者的管理

意大利肿瘤医学协会(AIOM,Italian Association of Medical Oncology) · 2020-12-01

2019 ASCO临床实践指南：含奥沙利铂辅助治疗III期结肠癌的持续时间

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2019-04-15

WSES指南：结肠癌和直肠癌急症-梗阻和穿孔

世界急诊外科学会(WSES,World Society of Emergency Surgery) · 2018-08-13

拓展阅读

ESMO临床实践指南：原发性结肠癌

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2010-10-05

2010 WSES 左侧梗阻性结肠癌管理指南

世界急诊外科学会(WSES,World Society of Emergency Surgery) · 2010-12-28

结肠癌规范化诊疗指南

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2013-04-23

2013 N-ECCO 欧洲克罗恩及溃疡性结肠癌患者护理共识声明

欧洲克罗恩病和结肠炎组织(ECCO,European Cron&#039;s and Colitis Organisation) · 2013-11-01

2017 ACPGBI指南：结肠癌，直肠癌以及肛门癌的管理

暂未更新 · 2017-06-20

WSES指南：结肠癌和直肠癌急症-梗阻和穿孔

世界急诊外科学会(WSES,World Society of Emergency Surgery) · 2018-08-13